1
|
Yang L, Su H, Sun Y, Zhang S, Cheng M, Liu Y. Recent Advances in Gold(I)-Catalyzed Approaches to Three-Type Small-Molecule Scaffolds via Arylalkyne Activation. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27248956. [PMID: 36558089 PMCID: PMC9785939 DOI: 10.3390/molecules27248956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Revised: 12/12/2022] [Accepted: 12/13/2022] [Indexed: 12/23/2022]
Abstract
Gold catalysts possess the advantages of water and oxygen resistance, with the possibility of catalyzing many novel chemical transformations, especially in the syntheses of small-molecule skeletons, in addition to achieving the rapid construction of multiple chemical bonds and ring systems in one step. In this feature paper, we summarize recent advances in the construction of small-molecule scaffolds, such as benzene, cyclopentene, furan, and pyran, based on gold-catalyzed cyclization of arylalkyne derivatives within the last decade. We hope that this review will serve as a useful reference for chemists to apply gold-catalyzed strategies to the syntheses of related natural products and active molecules, hopefully providing useful guidance for the exploration of additional novel gold-catalyzed approaches.
Collapse
Affiliation(s)
- Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
- Institute of Drug Research in Medicine Capital of China, Shenyang Pharmaceutical University, Benxi 117000, China
| | - Hongwei Su
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
- Institute of Drug Research in Medicine Capital of China, Shenyang Pharmaceutical University, Benxi 117000, China
| | - Yue Sun
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
- Institute of Drug Research in Medicine Capital of China, Shenyang Pharmaceutical University, Benxi 117000, China
| | - Sen Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
- Institute of Drug Research in Medicine Capital of China, Shenyang Pharmaceutical University, Benxi 117000, China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
- Institute of Drug Research in Medicine Capital of China, Shenyang Pharmaceutical University, Benxi 117000, China
- Correspondence: (M.C.); (Y.L.)
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
- Institute of Drug Research in Medicine Capital of China, Shenyang Pharmaceutical University, Benxi 117000, China
- Correspondence: (M.C.); (Y.L.)
| |
Collapse
|
2
|
Fu J, Li B, Zhou Z, Cheng M, Yang L, Liu Y. Formal total synthesis of macarpine via a Au(I)-catalyzed 6- endo- dig cycloisomerization strategy. Beilstein J Org Chem 2022; 18:1589-1595. [DOI: 10.3762/bjoc.18.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 11/14/2022] [Indexed: 11/24/2022] Open
Abstract
The formal total synthesis of macarpine was accomplished by the construction of a naphthol intermediate in Ishikawa’s synthetic route with two different synthetic routes. The convergent synthetic strategies feature the utilization of Au(I)-catalyzed cycloisomerizations of a 1,5-enyne and alkynyl ketone substrates, which were prepared by Sonogashira coupling reactions.
Collapse
|
3
|
Zhang J, Zhang S, Ding Z, Hou A, Fu J, Su H, Cheng M, Lin B, Yang L, Liu Y. Gold(I)-Catalyzed Tandem Intramolecular Methoxylation/Double Aldol Condensation Strategy Yielding 2,2′-Spirobi[indene] Derivatives. Org Lett 2022; 24:6777-6782. [DOI: 10.1021/acs.orglett.2c02653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Jingfu Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Sen Zhang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Zhixing Ding
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Anbin Hou
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Jiayue Fu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Hongwei Su
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Maosheng Cheng
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Bin Lin
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Lu Yang
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| | - Yongxiang Liu
- Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, Shenyang 110016, P.R. China
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
- Institute of Drug Research in Medicine Capital of China, Benxi 117000, P.R. China
| |
Collapse
|